Snot Force Alliance KY Bourbon + Roses: A Sinus, Allergy, and Airway Symposium 2024

Louisville, KY US
October 10, 2024 to October 13, 2024

The Snot Force Alliance conference is focused on the field of Allergy/Immunology, ENT and Pulmonology.  It is directed to physicians, physician assistants, nurse practitioners and administrators.  The purpose is to engage the audience through oral didactic presentations followed by group discussions.  Each presentation is reflective of a need or interest of in-depth conversation or study requested by the membership and/or board.  Case presentations are often utilized to solidify the objectives covered in each presentation.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunology and the Snot Force Alliance (SFA). The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 12.75 contact hours.

Commercial Support
This activity is supported in part by an Independent Medical Education Grant from Takeda.

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months.

Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be ineligible companies. Examples of ineligible companies include:

•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All relevant financial relationships with ineligible companies have been mitigated.

Course summary
Available credit: 
  • 12.75 AMA PRA Category 1 Credit™
  • 12.75 Attendance
  • 12.75 CBRN
Course opens: 
10/14/2024
Course expires: 
12/31/2025
Event starts: 
10/10/2024 - 6:00pm CDT
Event ends: 
10/13/2024 - 11:10am CDT
Rating: 
0

Snot Force Alliance KY Bourbon + Roses:  A Sinus, Allergy, and Airway Symposium 2024
The Seelbach Hilton, Louisville, KY 
October 10 - 13, 2024

Thursday, October 10
6:00 – 7:00 PM    PRODUCT THEATER – TBA (Non-CME)

Friday, October 11
730 – 8:00 AM     Coffee    
8:00 – 8:05 AM    Welcome and Opening Remarks, Thomas Higgins, MD
8:05 – 8:50 AM    Orbital Decompression, Jeremy Clark, MD; Mamie Higgins, MD; Dhruv Sharma, MD
8:50 – 9:30 AM    Malpractice, Leigh Schell
9:30 – 10:10 AM    Acute Airway Management and Anaphylaxis, John Anderson, MD; Elizabeth Burckhardt, MD; James Sublett, MD 
10:05 – 11:05 AM   Break in Exhibitor Hall    
10:45 – 11:30 AM   Chronic Rhinosinusitis Without Nasal Polyps:  The Disease Without a Biologic, James Sublett, MD; Corinna Levine, MD; Ed McCoul, MD; Art Wu, MD 
11:30 – 12:15 PM   Challenging Cases in Allergy, John Fahrenholz, MD; Lee Clore, MD; Akaber Halawi, MD
12:15 – 1:00 PM    Lunch     
1:00 – 1:45 PM   Atopic Dermatitis, Lee Clore, MD; Elizabeth Feuille, MD; Fatima Khan, MD 
1:45 – 2:25 PM   Upper Airway Cough Syndrome, Spencer Payne, MD; Benjamin Rogers, MD; Hiram Rivas Perez, MD; Wes Sublett, MD

Saturday, October 12
7:30 – 8:00 AM    Coffee     
8:00 – 8:05 AM    Welcome & Opening Remarks, Thomas Higgins, MD
8:05 – 8:50 AM    Challenging Cases in Rhinosinusitis, Rick Chandra, MD; Naveen Bhandarkar, MD; Christopher Roxbury, Ed McCoul, MD
8:50 – 9:30 AM    Dental Disease and Sinusitis, John Craig, MD; Bryan Burdette, DMD; Akaber Halawi, MD
9:30 – 10:10 AM    Skull Base, William Yao, MD; Jeffrey Bedrosian, MD; Mason Krysinski, MD; Kristin Mosier, MD
10:15 – 10:45 AM   Break in Exhibitor Hall  
10:45 – 11:30 AM   One Airway and the Esophagus, Joseph Turbyville, MD; Elizabeth Feuille, MD; Spencer Payne, MD; Benjamin Rogers, MD 
11:30 – 12:15 PM   Severe Uncontrolled Asthma, Wes Sublett, MD; Jean Kim, MD, PhD; John Fahrenholz, MD; Hiram Rivas Perez, MD 
12:15 – 1:00 PM    Lunch      
1:00 – 1:45 PM    Application of AI brought to you by ACAAI, Fatima Khan, MD
1:45 – 2:25 PM    Allergenic Diet:  Allergies and the Microbiome, Kristen Kloepfer, MD; Fatima Khan, MD; Melinda Thacker, MD

Sunday, October 13
8:15 – 8:20 AM    Welcome & Opening Remarks, Thomas Higgins, MD
8:20 – 9:00 AM    Vasculitis in the Airway, Kevin Byram, MD; Elizabeth Burckardt, MD; Allan Ramirez, MD; 
9:00 – 9:40 AM    Acquired Immunodeficiency, Narender Annapureddy, MD; John Fahrenholz, MD; Jean Kim, MD
9:40 – 10:20 AM    HAE, Doug Lotz, MD; Elizabeth Burckhardt, MD
10:20 – 11:00 AM   Mastocytosis, John Fahrenholz, MD; Lee S. Clore, Jr., MD
11:00 – 11:10 AM   Questions & Closing Remarks, Thomas Higgins, MD


Friday, October 11 (NON-CME)
7:00 – 7:45 AM    Product Theater Breakfast – Sponsored by Blueprint Medicines
12:15 – 1:00 PM    Product Theater Lunch – Sponsored by Regeneron
6:00 - 8:00 PM  Reception, Kentucky Derby Museum 

Saturday, October 12 (NON-CME)
7:00 – 7:45 AM    Product Theater Breakfast – Sponsored by Regeneron
12:25 – 1:05 PM    Product Theater Lunch – Sponsored by Takeda

Sunday, October 23 (NON-CME)
7:15 – 8:00 AM    Product Theater Breakfast – TBA

The Seelbach Hilton
500 S. 4th Street
Louisville, KY 40202
United States

All relevant financial relationships with ineligible companies have been mitigated.

John Anderson, MD
Advisor: CSL Behring, Takeda, Pharming, BioCryst, Pharvaris, CyclePharma; Speaker:  CSL Behring, Takeda, Pharming, BioCryst; Research:  CSL Behring, Takeda, Pharming, BioCryst, Ionis, KalVista, Pharvaris, Biomatrix

Narender Annapureddy, MD, Speaker
Consultant: GSK

Naveen Bhandarkar, MD, Speaker
Speaker: Optinose; Research: Lyra

Rick Chandra, MD, Speaker
Consultant: Sanofi Regeneron, Lyra, Optinose

Jeremy Clark, MD
Speaker: Amgen Tepezza

Lee S. Clore, Jr., MD, Speaker
Advisor: Incyte; Speaker: Sanofi Regeneron, GSK, Pharming, AstraZeneca; Research: Sanofi Regeneron, GSK, AstraZeneca, Novartis, Escient Pharmacetuicals, OM Pharma, Eli Lilly

John Craig, MD, Speaker
Advisor: Aerin Medical; Consultant: Aerin Medical

John Fahrenholz, MD, Speaker
Advisor: Blueprint Medicines, Cogent; Speaker: Blueprint Medicines; Researcher: Cogent

Thomas Higgins, MD, Moderator, Planner
Speaker: Optinose, Sanofi, Regeneron; Consultant:  Medtronic, Stryker; Reasearch:  Biohaven (Pfizer), Spirair, Cryano

Jean Kim, MD, Speaker
Research:  GSK, Genentech

Kristin Kloepfer, MD, Speaker
Speaker:  Regeneron

Corinna Levine, MD, PhD, Speaker
Research:  Medtronic

Doug Lotz, MD, Speaker
Speaker:  Takeda, BioCryst, Grifols, AstraZeneca

Edward McCoul, MD, Speaker
Consultant:  3D Matrix, AdvancedRX, Sanofi, Stryker, Zsquare

Spencer Payne, MD. Speaker
Ownership:  RefluxRaft; Speaker: Regeneron; Consultant: 3D Matrix

Benjamin Rogers, MD, Speaker
Advisor: Sanofi Regeneron; Speaker: Phathom

James Sublett, MD, Speaker
Speaker: GSK

Wes Sublett, MD, Speaker
Advisor: Bryn Pharma, Dermavant, Genentech, Pfizer, Regeneron, Sanofi; Speaker: AstraZeneca, Amgen, Sanofi, Regeneron; Research: Aimmune, ALK, AstraZeneca, BioCryst, Evidera, GSK, LEO Pharma, Novartis, Octapharma, Regeneron, Sanofi, Target, TEVA

Art Wu, MD, Speaker
Speaker: Sanofi Regeneron; Research: Aerin Medical, Optinose

William Yao, MD, Speaker
Consultant: Aerin Medical, Acclarent; Speaker:  Optinose

The following have no relevant financial relationships with ineligible companies to disclose:

Jeffrey Bedrosian, MD, Speaker
Elizabeth Burckardt, MD, Speaker
Bryan Burdette, DMD, Speaker
Kevin Byram, MD, Speaker
Elizabeth Feuille, MD, Speaker
Akaber Halawi, MD, Speaker
Mamie Higgins, MD, Speaker
Elisa Illing, MD, Planner
Fatima Khan, MD, Speaker
Mason Krysinski, MD, Speaker
Kristin Mosier, DMD, Speaker
Jean Owen, MBA, Planner
Hiram Rivas Perez, MD, Speaker
Allan Ramirez, Speaker
Christopher Roxbury, MD, Speaker
Leigh Schell, Speaker
Dhruv Sharm, MD, Speaker
Melinda Thacker, MD, Speaker
Joseph Turbyville, MD, Speaker

 

Available Credit

  • 12.75 AMA PRA Category 1 Credit™
  • 12.75 Attendance
  • 12.75 CBRN
Please login or create an account to take this course.